|
N4BP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.959900E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.178500E-04 |
| Normal-vs-Stage2 |
9.881700E-02 |
| Normal-vs-Stage3 |
1.509570E-01 |
| Normal-vs-Stage4 |
1.353390E-04 |
| Stage1-vs-Stage2 |
5.246000E-01 |
| Stage1-vs-Stage3 |
3.691600E-01 |
| Stage1-vs-Stage4 |
1.017350E-01 |
| Stage2-vs-Stage3 |
8.964200E-01 |
| Stage2-vs-Stage4 |
5.302400E-02 |
| Stage3-vs-Stage4 |
5.202400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.278800E-03 |
| Normal-vs-AfricanAmerican |
4.096400E-03 |
| Normal-vs-Asian |
1.033950E-01 |
| Caucasian-vs-AfricanAmerican |
6.790800E-01 |
| Caucasian-vs-Asian |
8.057400E-01 |
| AfricanAmerican-vs-Asian |
9.150800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.039000E-03 |
| Normal-vs-Female |
5.688500E-02 |
| Male-vs-Female |
4.441800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.80689999999384E-05 |
| Normal-vs-Extreme_Weight |
1.826550E-04 |
| Normal-vs-Obese |
2.902600E-01 |
| Normal-vs-Extreme_Obese |
2.519700E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.203600E-01 |
| Normal_Weight-vs-Obese |
3.977600E-03 |
| Normal_Weight-vs-Extreme_Obese |
6.144000E-01 |
| Extreme_Weight-vs-Obese |
1.271530E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.780200E-01 |
| Obese-vs-Extreme_Obese |
2.326200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.447000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.865900E-02 |
| Normal-vs-Age(61-80Yrs) |
1.641040E-04 |
| Normal-vs-Age(81-100Yrs) |
1.635330E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.307800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.622360E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.633700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.924470E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.898300E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.301410E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.243200E-03 |
| Normal-VS-Type2 PRCC |
1.245150E-04 |
| Normal-VS-KIRP CIMP |
2.778400E-01 |
| Normal-VS-Unclassified PRCC |
8.759200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.734200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.407000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.482360E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.384000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.062200E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
5.820200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.66649999999403E-05 |
| Normal-vs-N1 |
9.009600E-02 |
| Normal-vs-N2 |
2.763100E-03 |
| N0-vs-N1 |
6.836100E-02 |
| N0-vs-N2 |
4.063800E-01 |
| N1-vs-N2 |
9.198000E-02 |
|
|
